Casper Rokx

3.2k total citations
72 papers, 799 citations indexed

About

Casper Rokx is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Casper Rokx has authored 72 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 42 papers in Virology and 20 papers in Epidemiology. Recurrent topics in Casper Rokx's work include HIV Research and Treatment (42 papers), HIV/AIDS Research and Interventions (38 papers) and HIV/AIDS drug development and treatment (26 papers). Casper Rokx is often cited by papers focused on HIV Research and Treatment (42 papers), HIV/AIDS Research and Interventions (38 papers) and HIV/AIDS drug development and treatment (26 papers). Casper Rokx collaborates with scholars based in Netherlands, United States and Spain. Casper Rokx's co-authors include Bart Rijnders, Annelies Verbon, Jeroen J. A. van Kampen, Charles A. Boucher, Corine H. GeurtsvanKessel, Bart L. Haagmans, Marion Koopmans, Johannes P. C. van den Akker, Susanne Bogers and Annemiek A. van der Eijk and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Casper Rokx

65 papers receiving 788 citations

Peers

Casper Rokx
Dan Ouchi Spain
Valentine Marie Ferré France
Mahomed‐Yunus S. Moosa South Africa
Carmela Pinnetti Italy
Hammer Sm United States
Phillip P. Shadduck United States
Opass Putcharoen Thailand
Michael P. Busch United States
Bruno You France
Isabelle Charreau France
Dan Ouchi Spain
Casper Rokx
Citations per year, relative to Casper Rokx Casper Rokx (= 1×) peers Dan Ouchi

Countries citing papers authored by Casper Rokx

Since Specialization
Citations

This map shows the geographic impact of Casper Rokx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casper Rokx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casper Rokx more than expected).

Fields of papers citing papers by Casper Rokx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casper Rokx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casper Rokx. The network helps show where Casper Rokx may publish in the future.

Co-authorship network of co-authors of Casper Rokx

This figure shows the co-authorship network connecting the top 25 collaborators of Casper Rokx. A scholar is included among the top collaborators of Casper Rokx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Casper Rokx. Casper Rokx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Santos, Jéssica Cristina dos, Bram van Cranenbroek, W Vos, et al.. (2025). Circulating immune landscape and immune signatures in spontaneous HIV controllers. Frontiers in Immunology. 16. 1642482–1642482. 1 indexed citations
3.
4.
Jordans, Carlijn, et al.. (2024). Implementing HIV teams to improve HIV indicator condition-guided testing in general practitioner centers in the Netherlands. BMC Primary Care. 25(1). 440–440. 2 indexed citations
5.
6.
Jordans, Carlijn, Ward Hofhuis, Irene A.M. van der Avoort, et al.. (2024). High acceptability of point‐of‐care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands. International Journal of Gynecology & Obstetrics. 169(1). 155–162. 1 indexed citations
7.
Rokx, Casper, Els van Nood, Eric C. M. Van Gorp, et al.. (2023). Levels of Fibrinogen Variants Are Altered in Severe COVID-19. SHILAP Revista de lepidopterología. 7(3). e217–e225. 5 indexed citations
8.
9.
Izquierdo-Lara, Ray, Shringar Rao, Tsung Wai Kan, et al.. (2022). Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents. Nucleic Acids Research. 50(10). 5577–5598. 8 indexed citations
10.
Dijkstra, Maartje, Holly L. Peay, Casper Rokx, et al.. (2022). Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection. Journal of Virus Eradication. 8(2). 100072–100072. 10 indexed citations
11.
Jordans, Carlijn, Arvind Gharbharan, Barry Rockx, et al.. (2021). Potent neutralizing antibodies for severe COVID-19: A randomized clinical trial. 29(1). 34–34. 1 indexed citations
12.
Dijkstra, Maartje, Henrieke Prins, Jan M. Prins, et al.. (2021). Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment. BMJ Open. 11(11). e048582–e048582. 6 indexed citations
13.
Rokx, Casper, Colette Smit, Ferdinand W.N.M. Wit, et al.. (2020). Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study. PLoS Medicine. 17(5). e1003101–e1003101. 21 indexed citations
14.
GeurtsvanKessel, Corine H., Nisreen M.A. Okba, Zsὁfia Iglὁi, et al.. (2020). An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nature Communications. 11(1). 3436–3436. 231 indexed citations
15.
16.
Bon, Isabella, Annelies Verbon, Casper Rokx, et al.. (2019). Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1. Journal of Virological Methods. 276. 113778–113778. 16 indexed citations
17.
Rokx, Casper, Charles A. Boucher, Jeroen J. A. van Kampen, et al.. (2017). Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial. The Lancet HIV. 4(12). e547–e554. 76 indexed citations
18.
Rokx, Casper, Annelies Verbon, & Bart Rijnders. (2015). Short Communication: Lipids and Cardiovascular Risk After Switching HIV-1 Patients on Nevirapine and Emtricitabine/Tenofovir-DF to Rilpivirine/Emtricitabine/Tenofovir-DF. AIDS Research and Human Retroviruses. 31(4). 363–367. 11 indexed citations
19.
Rokx, Casper, Kirsten van Lom, Pieter Sonneveld, et al.. (2015). Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman’s disease complicated by hemophagocytic lymphohistiocytosis. International Journal of Hematology. 103(4). 469–472. 5 indexed citations
20.
Rokx, Casper, et al.. (2013). [Thrombocytopenia during pregnancy].. PubMed. 157(33). A6445–A6445.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan Ouchi Breakdown of academic impact, for papers by Valentine Marie Ferré Breakdown of academic impact, for papers by Mahomed‐Yunus S. Moosa Breakdown of academic impact, for papers by Carmela Pinnetti Breakdown of academic impact, for papers by Hammer Sm Breakdown of academic impact, for papers by Phillip P. Shadduck Breakdown of academic impact, for papers by Opass Putcharoen Breakdown of academic impact, for papers by Michael P. Busch Breakdown of academic impact, for papers by Bruno You Breakdown of academic impact, for papers by Isabelle Charreau
Rankless by CCL
2026